T Lymphoblastic Leukemia/Lymphoma
11 clinical trials · Condition
◉ Watch T Lymphoblastic Leukemia/Lymphoma
| Record | Firm | Date |
|---|---|---|
| Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies (NCT05290155) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2022-05-04 |
| Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia (NCT04762485) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study (NCT04480788) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2020-11-24 |
| Romidepsin Maintenance After Allogeneic Stem Cell Transplantation (NCT02512497) | Ohio State University Comprehensive Cancer Center | 2017-12-08 |
| Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715) | Mayo Clinic | 2016-01-19 |
Track T Lymphoblastic Leukemia/Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.